AURO-AMOXICLAV

auro pharma inc🇨🇦 Health Canada

Approval Id: 5a3661a2b9f25410
Drug Approval Canada Name: AURO-AMOXICLAV
Product Name: AURO-AMOXICLAV
Status: Marketed
Status Date: 2022-03-03
Original Market Date: 2022-03-03
Din: 02471671
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 08:12.16.08
Atc Original: J01CR02 AMOXICILLIN AND BETA-LACTAMASE INHIBITOR
Atc Name: j 01 cr 02
Aig Number: 0234720008
Company Name: auro pharma inc
Company Address: 3700 Steeles Avenue West, Suite 402, Woodbridge, Ontario, Canada, L4L 8K8

AMOXICILLIN (AMOXICILLIN TRIHYDRATE)

250 MG

CLAVULANIC ACID (CLAVULANATE POTASSIUM)

125 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

5a3661a2b9f25410

Type

Standard